Literature DB >> 19272414

Bidirectional regulation of stress responses by galanin in mice: involvement of galanin receptor subtype 1.

K Mitsukawa1, X Lu, T Bartfai.   

Abstract

The neuropeptide galanin has been shown to play a role in psychiatric disorders as well as in other biological processes including regulation of pain threshold through interactions with three G-protein coupled receptors, galanin receptor subtypes 1-3 (GalR1-3). While most of the pharmacological studies on galanin in stress-related disorders have been done with rats, the continuous development of genetically engineered mice involving galanin or its receptor subtype(s) validates the importance of mouse pharmacological studies. The present study on mice examined the homeostatic, endocrinological and neuroanatomical effects of the galanin, injected intracerebroventricularly (i.c.v.), in regulation of stress responses after restraint stress. Furthermore, the roles of GalR1 on these effects were studied using GalR1 knockout (KO) mice. The core body temperature and the locomotor activity were monitored with radio telemetry devices. Galanin (i.c.v.) decreased locomotor activity and exerted a bidirectional effect on the restraint stress-induced hyperthermia; a high dose of galanin significantly attenuated the stress-induced hyperthermic response, while a low dose of galanin moderately enhanced this response. The bidirectional effect of galanin was correlated with changes in stress hormone levels (adrenocorticotropic hormone and corticosterone). To neuroanatomically localize the effects of galanin on stress response, cFos immunoreactivity was assessed in galanin receptor rich areas; paraventricular nucleus (PVN) of the hypothalamus and the locus coeruleus (LC), respectively. A high dose of galanin significantly induced cFos activity in the LC but not in the PVN. In GalR1KO mice, a high dose of galanin failed to induce any of the above effects, suggesting the pivotal role of GalR1 in decreased locomotor activity and stress-resistant effects caused by galanin i.c.v. injection studied here.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19272414      PMCID: PMC2673341          DOI: 10.1016/j.neuroscience.2009.02.063

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  80 in total

Review 1.  Pharmacological evidence supporting a role for galanin in cognition and affect.

Authors:  C C Wrenn; J N Crawley
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-01       Impact factor: 5.067

Review 2.  How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions.

Authors:  R M Sapolsky; L M Romero; A U Munck
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

Review 3.  Galanin receptor subtypes.

Authors:  T A Branchek; K E Smith; C Gerald; M W Walker
Journal:  Trends Pharmacol Sci       Date:  2000-03       Impact factor: 14.819

4.  Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608).

Authors:  Will P J M Spooren; Philippe Schoeffter; Fabrizio Gasparini; Rainer Kuhn; Conrad Gentsch
Journal:  Eur J Pharmacol       Date:  2002-01-25       Impact factor: 4.432

5.  Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala.

Authors:  Habibeh Khoshbouei; Marco Cecchi; Stephanie Dove; Martin Javors; David A Morilak
Journal:  Pharmacol Biochem Behav       Date:  2002-03       Impact factor: 3.533

6.  Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze.

Authors:  P Ferris; E Seward; G R Dawson
Journal:  J Psychopharmacol       Date:  2001-06       Impact factor: 4.153

7.  Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice.

Authors:  Andrew Holmes; Rebecca J Yang; Jacqueline N Crawley
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

Review 8.  Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease.

Authors:  J N Crawley
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

Review 9.  Galanin and spinal pain mechanisms: where do we stand in 2008?

Authors:  X-J Xu; T Hökfelt; Z Wiesenfeld-Hallin
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

Review 10.  Galanin, galanin receptors and drug targets.

Authors:  K Mitsukawa; X Lu; T Bartfai
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

View more
  8 in total

1.  Receptor subtype-dependent galanin actions on gamma-aminobutyric acidergic neurotransmission and ethanol responses in the central amygdala.

Authors:  Michal Bajo; Samuel G Madamba; Xiaoying Lu; Lisa M Sharkey; Tamas Bartfai; George Robert Siggins
Journal:  Addict Biol       Date:  2011-09-28       Impact factor: 4.280

2.  Locomotion and self-administration induced by cocaine in 129/OlaHsd mice lacking galanin.

Authors:  Christian Brabant; Anna S Kuschpel; Marina R Picciotto
Journal:  Behav Neurosci       Date:  2010-12       Impact factor: 1.912

3.  Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain.

Authors:  Molly L Rovin; Katherine A Boss-Williams; Reid S Alisch; James C Ritchie; David Weinshenker; Charles H K West; Jay M Weiss
Journal:  Neuropeptides       Date:  2012-02-10       Impact factor: 3.286

4.  Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe.

Authors:  Erwan Le Maître; Swapnali Shantaram Barde; Miklos Palkovits; Rochellys Diaz-Heijtz; Tomas G M Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

5.  Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms.

Authors:  Marine Jequier Gygax; Brian D Klein; H Steve White; Mimi Kim; Aristea S Galanopoulou
Journal:  Epilepsy Res       Date:  2013-10-28       Impact factor: 3.045

Review 6.  Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors.

Authors:  Marina R Picciotto; Christian Brabant; Emily B Einstein; Helen M Kamens; Nichole M Neugebauer
Journal:  Brain Res       Date:  2009-08-20       Impact factor: 3.252

7.  A Novel Integrative Mechanism in Anxiolytic Behavior Induced by Galanin 2/Neuropeptide Y Y1 Receptor Interactions on Medial Paracapsular Intercalated Amygdala in Rats.

Authors:  Manuel Narváez; Dasiel O Borroto-Escuela; Luis Santín; Carmelo Millón; Belén Gago; Antonio Flores-Burgess; Miguel A Barbancho; Miguel Pérez de la Mora; José Narváez; Zaida Díaz-Cabiale; Kjell Fuxe
Journal:  Front Cell Neurosci       Date:  2018-05-01       Impact factor: 5.505

8.  Reduction of stress responses in honey bees by synthetic ligands targeting an allatostatin receptor.

Authors:  Adrià Sánchez-Morales; Véronique Gigoux; Minos-Timotheos Matsoukas; Laura Perez-Benito; Daniel Fourmy; Ramón Alibes; Félix Busqué; Arnau Cordomí; Jean-Marc Devaud
Journal:  Sci Rep       Date:  2022-10-06       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.